[(S)-(−)-2,2′-Bis(di-p-tolylphosphino)-1,1′-binaphthyl]palladium(II) chloride
S486889-100MG / 100MG
CAS:215597-19-6
[(S)-(−)-2,2′-Bis(di-p-tolylphosphino)-1,1′-binaphthyl]palladium(II) chloride
S486889-500MG / 500MG
CAS:215597-19-6
(1S,4S)-(−)-2-(4-Fluorophenyl)-2,5-diazabicyclo[2.2.1]heptane hydrobromide
S487005-500MG / 500MG
CAS:308103-49-3
(1S,4S)-(−)-2-(4-Chlorophenyl)-2,5-diazabicyclo[2.2.1]heptane hydrobromide
S487006-500MG / 500MG
CAS:308103-51-7
(S)-5-Benzyl-2-mesityl-6,6-dimethyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium tetrafluoroborate ≥97%
S487371-100MG / 100MG
CAS:925706-40-7
(S)-5-Benzyl-2-mesityl-6,6-dimethyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium tetrafluoroborate ≥97%
S487371-500MG / 500MG
CAS:925706-40-7
(S)-5-Benzyl-2-mesityl-6,6-dimethyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium tetrafluoroborate ≥97%
S487371-50MG / 50MG
CAS:925706-40-7
SAM Formation reagent for carboxylic acid terminated monolayer on gold surface
S487441-1SET / 1SET